Top 3D Printing companies in Australia by Debt to Equity Ratio
Australia
# |
Name |
Debt to Equity Ratio |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
1.19
|
June 30, 2024 | USD 1.90 | 0.29% |
|
Australia |
|
| 2 |
0.56
|
June 30, 2024 | USD 0.74 | 0.62% |
|
Australia |
|
| 3 |
0.32
|
June 30, 2024 | USD 10.31 | 2.62% |
|
Australia |
|
| 4 |
0.25
|
June 30, 2024 | USD 1.90 | -4.74% |
|
Australia |
|
| 5 |
0.21
|
June 30, 2024 | USD 1.23 | -0.40% |
|
Australia |
|
| 6 |
0.16
|
June 30, 2024 | USD 5.16 | 1.74% |
|
Australia |
|
| 7 |
0.13
|
June 30, 2024 | USD 195.76 | 0.28% |
|
Australia |
|
| 8 |
0.13
|
Dec. 31, 2023 | USD 1.45 | -3.95% |
|
Australia |
|
| 9 |
0.12
|
Dec. 31, 2023 | USD 18.33 | -0.84% |
|
Australia |
|
| 10 |
0.08
|
Dec. 31, 2023 | USD 6.16 | 2.82% |
|
Australia |
|
| 11 |
0.01
|
June 30, 2024 | USD 181.62 | 2.38% |
|
Australia |
|
| 12 |
0.01
|
June 30, 2024 | USD 3.77 | 2.85% |
|
Australia |
Frequently Asked Questions
-
Which 3D Printing company in Australia has the highest Debt to Equity Ratio ?
The 3D Printing company in Australia with the highest Debt to Equity Ratio is Integral Diagnostics Limited (ASX: IDX.AX) at 1.19.
-
Which 3D Printing company in Australia has the lowest Debt to Equity Ratio ?
The 3D Printing company in Australia with the lowest Debt to Equity Ratio is Silex Systems Limited (ASX: SLX.AX) at 0.01.
-
What are the top 10 3D Printing companies in Australia by Debt to Equity Ratio ?
The top 10 3D Printing companies in Australia by Debt to Equity Ratio are Integral Diagnostics Limited, Monash IVF Group Limited, Codan Limited, Mesoblast Limited, PolyNovo Limited, PWR Holdings Limited, Cochlear Limited, Cyclopharm Limited, Telix Pharmaceuticals Limited and Anteris Technologies Ltd.
-
What are the bottom 10 3D Printing companies in Australia by Debt to Equity Ratio ?
The bottom 10 3D Printing companies in Australia by Debt to Equity Ratio are Silex Systems Limited, Pro Medicus Limited, Anteris Technologies Ltd, Telix Pharmaceuticals Limited, Cyclopharm Limited, Cochlear Limited, PWR Holdings Limited, PolyNovo Limited, Mesoblast Limited and Codan Limited.
